BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3632149)

  • 1. Impact of a therapeutic drug monitoring program for digoxin.
    Wing D; Duff HJ
    Arch Intern Med; 1987 Aug; 147(8):1405-8. PubMed ID: 3632149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Educational effort and CQI program improves ordering of serum digoxin levels.
    Wade WE; McCall CY
    Hosp Formul; 1994 Sep; 29(9):657-9. PubMed ID: 10137062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pharmacist intervention on the use of serum drug assays.
    Levin B; Cohen SS; Birmingham PH
    Am J Hosp Pharm; 1981 Jun; 38(6):845-51. PubMed ID: 7246556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Audit of digoxin prescribing in ambulatory patients.
    Wiser TH; Michocki RJ; Knapp DA; Knapp DA; Ilioff SM
    Hosp Pharm; 1984 Dec; 19(12):811-6. PubMed ID: 10269044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of data collection method on results of serum digoxin concentration audit.
    Makela EH; Davis SK; Piveral K; Miller WA; Pleasants RA; Gadsden RH; Leman RB
    Am J Hosp Pharm; 1988 Jan; 45(1):126-30. PubMed ID: 3348225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum digoxin level (SDL) utilization review.
    Parker WA; Reid LW
    Can J Hosp Pharm; 1978; 31(3):97-9. PubMed ID: 10307387
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic drug monitoring: improved performance through educational intervention.
    D'Angio RG; Stevenson JG; Lively BT; Morgan JE
    Ther Drug Monit; 1990 Mar; 12(2):173-81. PubMed ID: 2315974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoring.
    Klamerus KJ; Munger MA
    Am J Hosp Pharm; 1988 Sep; 45(9):1887-93. PubMed ID: 3228120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary audit of digoxin.
    Keys PW; DeSantis D; Duffy MG
    Am J Hosp Pharm; 1978 Aug; 35(8):935-8. PubMed ID: 677140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a therapeutic drug monitoring program for theophylline in a teaching hospital.
    Wing DS; Duff HJ
    Drug Intell Clin Pharm; 1987 Sep; 21(9):702-6. PubMed ID: 3652932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial drug use monitoring by a hospital pharmacy.
    Greenlaw CW
    Am J Hosp Pharm; 1977 Aug; 34(8):835-8. PubMed ID: 900135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring: an assessment of current practices at Fremantle Hospital.
    Batty K
    Hosp Pharm; 1993 Oct; 28(10):1029-32, 1035-6. PubMed ID: 10129138
    [No Abstract]   [Full Text] [Related]  

  • 13. A utilization review of digoxin assays: sampling patterns and use.
    Guernsey BG; Hokanson JA; Ingrim NB; Fuchs JE; Sanders AG; Doutre WH; Bryant SG
    Hosp Pharm; 1984 Mar; 19(3):187-92, 196-200. PubMed ID: 10265848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a computerized digoxin pharmacokinetic consultation service.
    Rich DS; Mahoney CD; Jeffrey LP; Pezzullo JC
    Hosp Pharm; 1981 Jan; 16(1):23-7. PubMed ID: 10249750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin: a quality assurance model for concurrent drug monitoring.
    Mattei TJ; Karnack CM; Rihn TL; Eder RA
    Hosp Pharm; 1985 Apr; 20(4):235-7, 240-1. PubMed ID: 10270729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center.
    Patel RJ; Gray DR; Pierce R; Jafari M
    Am J Manag Care; 1999 Apr; 5(4):465-74. PubMed ID: 10387386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels.
    Howanitz PJ; Steindel SJ
    Arch Pathol Lab Med; 1993 Jul; 117(7):684-90. PubMed ID: 8323428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of therapeutic drug monitoring.
    Gardner DM; Hardy BG
    Can J Hosp Pharm; 1990 Feb; 43(1):7-12, xii. PubMed ID: 10113128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England.
    Wickens HJ; Jacklin A
    J Antimicrob Chemother; 2006 Dec; 58(6):1230-7. PubMed ID: 17030518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.